Protein kinase C and other diacylglycerol effectors in cancer
The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
Almost three decades after the discovery of protein kinase C (PKC), we still have only a partial understanding of how this family of serine/threonine kinases is involved in tumour promotion. PKC isozymes - effectors of diacylglycerol (DAG) and the main targets of phorbol-ester tumour promoters - have important roles in cell-cycle regulation, cellular survival, malignant transformation and apoptosis. How do PKC isozymes regulate these diverse cellular processes and what are their contributions to carcinogenesis? Moreover, what is the contribution of all phorbol-ester effectors, which include PKCs and small G-protein regulators? We now face the challenge of dissecting the relative contribution of each DAG signal to cancer progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C (PKC) and other effector proteins, ultimately influencing microglial processes such as migration, phagocytosis, cytokine secretion, and metabolic responses. 13 , 16 , 17”
From Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells (2025) · cites this paper as [17]
In the citing paper
“and DAG leading to activation of protein kinase C (PKC) isozymes, the NLRP3 inflammasome [31, 34], as well as other proteins [77].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [77]
In the citing paper
“Conversely, phorbol esters, the naturally occurring activating ligands of PKC, showed tumor‐promoting functions, suggesting that PKC could be an oncogene [111, 120, 121].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [121]
Citations
Cites
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725 · cited 3×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
BackgroundKishimoto, A., Takai, Y., Mori, T., Kikkawa, U., & Nishizuka, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85886-6 · Cited by 1,303
Protein kinase C as a possible receptor protein of tumor‐promoting phorbol esters
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., & Nishizuka, Y. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44245-1 · Cited by 881 · cited 2×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731 · cited 1×
“Nishizuka and colleagues found that PKC could be activated by the lipid diacylglycerol (DAG) in the presence of phosphatidylserine as a cofacto”
BackgroundRasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding Motifs
Ebinu, J. O., Bottorff, D. A., Chan, E. Y. W., Stang, S. L., Dunn, R. J., & Stone, J. C. (1998) · Science · doi:10.1126/science.280.5366.1082 · Cited by 689
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., & Weichselbaum, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00305.x · Cited by 670
Multiple pathways control protein kinase C phosphorylation
Parekh, D. B., Ziegler, W., & Parker, P. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.496 · Cited by 601 · cited 1×
“The mechanisms involved in PKC activation have been extensively studie”
BackgroundTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
Background
Research works printed but not linked: 1
- Wu, E. X. et al. PKCβ: a rational therapeutic target in diffuse large B-cell lymphoma. Blood 100, 202A–202A (2002).
Cited by
Items 501–600 of 1,000
A Novel Cross-talk in Diacylglycerol Signaling
Griner, E., Caino, M. C., Sosa, M. S., Colón‐González, F., Chalmers, M. J., Mischak, H., & Kazanietz, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.099036 · Cited by 19
Self-citationAnalysing the expression of protein kinase C eta in human hepatocellular carcinoma
Lu, H., Chou, F., Yeh, K., Chang, Y., Hsu, N. C.-H., & Chang, J. (2009) · Pathology · doi:10.3109/00313020903273076 · Cited by 19
aPKC alters TGFβ response in NSCLC cells via both Smad-dependent and Smad-independent pathways
Gunaratne, A., Chan, E. W. C., El-Chabib, T. H., Carter, D., & Guglielmo, G. M. D. (2014) · Journal of Cell Science · doi:10.1242/jcs.155440 · Cited by 19
“The aPKC isoforms, which consist of PKCi and PKCf, are a subset of the protein kinase C family that are Ca and diacylglycerol (DAG)-independent (Griner and Kazanietz, 2007).”
BackgroundPhospholipid Biosynthesis: An Unforeseen Modulator of Nuclear Metabolism
Qiu, H., & Ye, C. (2025) · Biology of the Cell · doi:10.1111/boc.70002 · Cited by 18
“An increase in plasma membrane DAG levels results in the activation and intracellular relocation of PKC isozymes to organelles such as the mitochondria, ER, Golgi apparatus, and nucleus (Griner and Kazanietz 2007).”
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity
Sahu, U., Mullarkey, M. P., Murphy, S. A., Anderson, J. C., Putluri, V., Kamal, A. H. M., Park, J. H., Lee, T. J., Ling, A. L., Kaipparettu, B. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58911-2 · Cited by 19
“Using a pan-kinome functionality assay we also observed activation of PKC, a class of serine/threonine kinases that acts as a pleiotropic regulator of cell proliferation, differentiation, and survival 50 .”
Protein Kinase Cβ Modulates Ligand-induced Cell Surface Death Receptor Accumulation
Meng, X. W., Heldebrant, M. P., Flatten, K. S., Loegering, D. A., Dai, H., Schneider, P. A., Gomez, T. S., Peterson, K. L., Trushin, S. A., Hess, A. D., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057638 · Cited by 19
Wang, Y., Tang, C., Yao, S., Lai, H., Li, R., Xu, J., Wang, Q., Fan, X., Wu, Q., Leung, E. L., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153100 · Cited by 18
Yamada, K., Kizawa, R., Yoshida, A., Koizumi, R., Motohashi, S., Shimoyama, Y., Hannya, Y., Yoshida, S., Oikawa, T., Shimoda, M., et al. (2022) · Cancer Science · doi:10.1111/cas.15386 · Cited by 19
Petiti, J. P., Paul, A. L. D., Gutiérrez, S., Palmeri, C. M., Mukdsi, J. H., & Torres, A. I. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.04.015 · Cited by 18
“Furthermore, the atypical PKCs, which include PKC and PKC / , are unresponsive to both Ca2+ and DAG/phorbol esters (Ohno and Nishizuka, 2002; Griner and Kazanietz, 2007).”
Yang, Y., & Igumenova, T. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065699 · Cited by 18
“Modulation of PKC activity in isoform-specific manner – both for therapeutic and research purposes – is one of the current challenges in the PKC field [3,7].”
Zhang, C., Zhang, Z., Zhao, Q., Wang, X., Ji, H., & Zhang, Y. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9444-x · Cited by 18
“The neuroprotective actions of this pathway are mediated in part by the up-regulation of the pro-survival factors Bcl-2 and Bcl-xL (Griner and Kazanietz 2007).”
BackgroundNguyen, C. H., Brenner, S., Huttary, N., Li, Y., Atanasov, A. G., Dirsch, V. M., Holzner, S., Stadler, S., Riha, J., Krieger, S., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.06.022 · Cited by 18
Curcumin Inhibits Protein Kinase Cα Activity by Binding to Its C1 Domain
Pany, S., You, Y., & Das, J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00932 · Cited by 18
Chen, M., Yang, M., Chang, M., Tyan, Y., & Chen, Y. A. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114607 · Cited by 18
Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms
Nakashima, M., Hamajima, H., Xia, J., Iwane, S., Kwaguchi, Y., Eguchi, Y., Mizuta, T., Fujimoto, K., Ozaki, I., & Matsuhashi, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.05.002 · Cited by 17
“PKCδ and PKCε play differential roles in the development and progression of cancer by regulating proliferation, invasion and apoptosis [48].”
BackgroundAzbazdar, Y., Demirci, Y., Heger, G., Ipekgil, D., Karabicici, M., & Özhan, G. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13520 · Cited by 17
“DAG, by either DGK-mediated phosphorylation into phosphatidic acid or activating protein kinase C, supports tumor growth, and HCC progression [70 – 72].”
BackgroundAngileri, F., Roy, V., Morrow, G., Scoazec, J., Gadot, N., Orejuela, D., & Tanguay, R. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.002 · Cited by 19
PKCα promotes generation of reactive oxygen species via DUOX2 in hepatocellular carcinoma
Wang, J., Shao, M., Liu, M., Peng, P., Li, L., Wu, W., Wang, L., Duan, F., Zhang, M., Song, S., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.021 · Cited by 18
“These results suggest that among the members of conventional PKCs, PKCa, but not PKCbI or PKCbII, was involved in the production of ROS in hepatocellular carcinoma.”
BackgroundInfluentialMuthusamy, S., Shukla, S., Amin, M. R., Cheng, M., Orenuga, T., Dudeja, P. K., & Malakooti, J. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00363.2011 · Cited by 19
“Phorbol 12-myristate 13-acetate (PMA), a diaceylglycerol structural analog, mimics DAG and modulates diverse cellular functions by direct binding to the DAG-binding site of the cPKCs and nPKCs (16, 42).”
BackgroundEmerging Targets of the GnRH Receptor: Novel Interactions with Wnt Signalling Mediators
Gardner, S., & Pawson, A. J. (2009) · Neuroendocrinology · doi:10.1159/000165377 · Cited by 16
“PKC is thought to be involved in antiproliferation and apoptosis, and PKC has been implicated in survival and proliferation [Griner and Kazanietz, 2007].”
BackgroundPal, D., Outram, S. P., & Basu, A. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.028 · Cited by 17
“The contrasting function of PKCη is not unique and several other PKC isoforms have been shown to exert opposite effects depending on the cell type [1,9,27,32].”
InfluentialGarcía, L. C., Donadio, L. G., Mann, E., Kolusheva, S., Kedei, N., Lewin, N. E., Hill, C., Kelsey, J. S., Yang, J., Esch, T. E., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.04.024 · Cited by 17
Xu, Y.-M., Li, Z., Zhang, C., Zhang, S., Ji, Y., & Chen, F. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0341-4 · Cited by 17
“PKCε, as a key signaling transducer, has been linked to the regulation of various cellular signaling pathways implicated in mitogenesis, proliferation, differentiation, survival and cancer progression (Griner and Kazanietz 2007; Garczarczyk et al. 2009; Gorin and Pan 2009; Toton et al. 2011).”
BackgroundGundimeda, U., Schiffman, J. E., Gottlieb, S., Roth, B. I., & Gopalakrishna, R. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp164 · Cited by 17
Protein phosphorylation pathways disruption by pesticides
Magnarelli, G., & Fonovich, T. M. (2013) · Advances in Biological Chemistry · doi:10.4236/abc.2013.35050 · Cited by 18
“While most studies report down-regulated expression of PKCα, β and δ in human cancers, PKCε, PKC α and δ have often been found to be over expressed in various cancers relative to the normal tissue [56,61].”
BackgroundCai, K., & Sewer, M. B. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035634 · Cited by 18
Alam, S., Mattern‐Schain, S. I., & Best, M. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12540-5 · Cited by 18
Diacylglycerol Kinase Malfunction in Human Disease and the Search for Specific Inhibitors
Mérida, I., Arranz‐Nicolás, J., Torres‐Ayuso, P., & Ávila‐Flores, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_221 · Cited by 18
Regulation of the SIRT1 signaling pathway in NMDA-induced Excitotoxicity
Yang, X., Sun, X., Wu, J., Ma, J.-T., Si, P., Yin, L., Zhang, Y., Yan, L., & Zhang, C. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.01.009 · Cited by 17
Getz, M., Swanson, L., Sahoo, D., Ghosh, P., & Rangamani, P. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-10-0630 · Cited by 18
Mamidi, N., Borah, R., Sinha, N., Jana, C., & Manna, D. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp304787j · Cited by 17
Predicting neuroblastoma using developmental signals and a logic-based model
Kasemeier‐Kulesa, J. C., Schnell, S. D., Woolley, T. E., Spengler, J. A., Morrison, J. A., McKinney, M. C., Pushel, I., Wolfe, L. A., & Kulesa, P. M. (2018) · Biophysical Chemistry · doi:10.1016/j.bpc.2018.04.004 · Cited by 16
“These include: (1) MAPK, a reporter of cell differentiation based on several studies of neuroblastoma differentiation (38,39,40,41) and normal receptor tyrosine kinase signaling (42,43); (2) mTOR, was selected as a reporter of angiogenesis from studies in neuroblastoma (44,45,46) and as a target of…”
BackgroundMachado, R. A. C., Stojevski, D., Landtsheer, S. D., Lucarelli, P., Baron, A., Sauter, T., & Schaffner‐Reckinger, E. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00710-5 · Cited by 16
Di, S., An, X., Pang, B., Wang, T., Wu, H., Wang, J., & Li, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112254 · Cited by 16
Su, S., Hsin, C., Lu, Y., Chuang, C., Ho, Y., Yeh, F.-L. J., Yang, S., & Lin, C. (2023) · Cancers · doi:10.3390/cancers15051552 · Cited by 17
“The impact of TPA-mediated PKC signaling on cancer metastasis has been well-documented in various cancer types [13–16].”
BackgroundInfluentialTeng, H., Ballim, R. D., Mowla, S., & Prince, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021360 · Cited by 16
PKCδ is required for porcine reproductive and respiratory syndrome virus replication
Zhao, H., Guo, X.-K., Bi, Y., Zhu, Y., & Feng, W.-H. (2014) · Virology · doi:10.1016/j.virol.2014.07.040 · Cited by 16
Hiragaki, S., Uno, T., & Takeda, M. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0747-9 · Cited by 17
“Protein kinases including protein kinase C (PKC) regulate various signal transduction pathways related to cell proliferation, morphogenesis, apoptosis, and interneural communications (Amadio et al. 2006; Griner and Kazanietz 2007; Nishizuka 1995).”
BackgroundStat3 Activity Is Required for Gap Junctional Permeability in Normal Rat Liver Epithelial Cells
Geletu, M., Chaize, C., Arulanandam, R., Vultur, A., Kowolik, C. M., Anagnostopoulou, A., Jove, R., & Raptis, L. H. (2009) · DNA and Cell Biology · doi:10.1089/dna.2008.0833 · Cited by 16
“…phosphorylation of Cx43 at tyr247 and tyr265 (Lampe and Lau, 2004; Warn-Cramer and Lau, 2004), or indirectly through activation of the Protein kinase C or the Ras = Raf = Mek = Erk pathways (Zhou et al. , 1999; Lampe et al. , 2000; Shah et al. , 2002; Bao et al. , 2004; Griner and Kazanietz, 2007).”
Investigation of anti-cancer mechanisms by comparative analysis of naked mole rat and rat
Yang, Z., Zhang, Y., & Chen, L. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-s2-s5 · Cited by 16
“PKCs were generally abnormally regulated in the cancers of the breast, prostate, kidney and liver [16], and remained”
BackgroundRaifman, O., Kolusheva, S., Comin, M. J., Kedei, N., Lewin, N. E., Blumberg, P. M., Márquez, V. E., & Jelinek, R. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07477.x · Cited by 18
“signaling pathways feature prominently in the development and properties of cancer cells [2,3] and, in consequence, PKC isozymes are being actively pursued as therapeutic targets for cancer [4].”
BackgroundUpdate on Metastatic Uveal Melanoma: Progress and Challenges
Spagnolo, F., Picasso, V., Spano, L., Tanda, E. T., Venzano, C., & Queirolo, P. (2016) · BioDrugs · doi:10.1007/s40259-016-0167-4 · Cited by 17
Wu, C., Yang, M., Lee, Y., & Wang, C. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.08.021 · Cited by 16
Synthesis and evaluation of biological activities of vibsanin A analogs
Matsuki, W., Miyazaki, S., Yoshida, K., Ogura, A., Sasazawa, Y., Takao, K., & Simizu, S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.059 · Cited by 16
Bräutigam, K., Bauerschlag, D., Weigel, M. T., Biernath-Wüpping, J., Bauknecht, T., Arnold, N., Maass, N., & Meinhold-Heerlein, I. M. (2009) · Translational Oncology · doi:10.1593/tlo.09121 · Cited by 18
“Protein kinases C (PKCs) are a family of serine/threonine kinases comprising at least 12 isoforms that are involved in tumor formation and progression [5,6].”
BackgroundG Protein‐Coupled Receptor Signaling: Implications and Therapeutic Development Advances in Cancers
Khan, I. R., Khurshid, S., Almawash, S., Kumar, R., Akil, A. A., Bhat, A. A., & Macha, M. A. (2025) · MedComm · doi:10.1002/mco2.70375 · Cited by 15
Kao, H.-H., Wu, C.-J., Won, S., Shin, J.-W., Liu, H., & Su, C. (2011) · Plant Foods for Human Nutrition · doi:10.1007/s11130-011-0228-2 · Cited by 15
“Nuclear PKC-δ has been suggested to regulate cell cycle and induce apoptosis by interacting with DNA-dependent protein kinase, nuclear lamina, and topoisomerase IIα [11].”
BackgroundInfluentialBär, S., Rommelaere, J., & Nüesch, J. P. F. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004703 · Cited by 17
“This is best-studied of the widely expressed nPKCs PKCε and PKCδ, which respectively promote cell survival and death [16].”
BackgroundHuman thrombopoiesis depends on Protein kinase C /protein kinase C functional couple
Carubbi, C., Masselli, E., Martini, S., Galli, D., Aversa, F., Mirandola, P., Italiano, J. E., Gobbi, G., & Vitale, M. (2016) · Haematologica · doi:10.3324/haematol.2015.137984 · Cited by 16
“yang” because of their antithetical roles in several cellular functions.(18) PKCε is largely considered as an oncogene because of its anti-apoptotic and pro-proliferative functions,(19) whereas PKCδ generally slows down proliferation and induces cell cycle arrest and apoptosis.”
BackgroundG Protein-Coupled Receptor-Mediated Calcium Signaling in Astrocytes
Pittà, M. D., Ben‐Jacob, E., & Berry, H. (2019) · Springer series in computational neuroscience · doi:10.1007/978-3-030-00817-8_5 · Cited by 19
Kim, K., Chung, C., Kim, J., Lee, D., Cho, S. Y., Lee, T. H., Cho, H. J., & Yeo, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-5992-7 · Cited by 15
Mandić, M., Misirkic-Marjanovic, M., Vucicevic, L. M., Jovanović, M., Bošnjak, M., Perović, V., Ristic, B. Z., Ćirić, D., Harhaji-Trajkovic, L. M., & Trajković, V. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120481 · Cited by 15
Kang, M.-S., Na, H. Y., Ahn, S., Kim, J.-W., Lee, J. H., 안소연, Lee, J. H., Youk, J., Kim, H. T., Kim, S. H., et al. (2022) · eLife · doi:10.7554/elife.78636 · Cited by 16
“In GB-A2 (Figure 4 3A-C), clone F, which acquired PRKCD (30, 31) I153L, expanded from 0.”
BackgroundInfluentialRegulation of TGFβ receptor trafficking and signaling by atypical protein kinase C
Gunaratne, A., Benchabane, H., & Guglielmo, G. M. D. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.012 · Cited by 19
Role of cPKCα and nPKCε in EGF-Stimulated Goblet Cell Proliferation
Shatos, M. A., Hodges, R. R., Oshi, Y., Bair, J. A., Zoukhri, D., Kublin, C. L., Lashkari, K., & Dartt, D. A. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2467 · Cited by 15
Sassano, A., Altman, J. K., Gordon, L. I., & Platanias, L. C. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.668287 · Cited by 15
Imbalance in Protein Thiol Redox Regulation and Cancer-Preventive Efficacy of Selenium
Gopalakrishna, R., Gundimeda, U., Zhou, S., Zung, K., Forell, K., & Holmgren, A. (2016) · Reactive Oxygen Species · doi:10.20455/ros.2016.851 · Cited by 15
“PKC has oncogenic potential and is a promitogenic and prosurvival enzyme [76].”
BackgroundInfluentialImaging of cancer lipid metabolism in response to therapy
Arlauckas, S. P., Browning, E. A., Poptani, H., & Delikatny, E. J. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4070 · Cited by 15
Smalley, T. B., Metcalf, R. S., Patel, R. S., Islam, S. M. A., Bommareddy, R. R., & Acevedo-Duncan, M. E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00209 · Cited by 15
“These proteins phosphorylate the serine and threonine residues of substrates and are generally activated by compounds such as diacylglycerol (DAG), calcium (Ca2+) and phorbol esters (9).”
BackgroundInfluentialNeocomplanines A and B, a Complanine Family Isolated from the Marine Fireworm
NAKAMURA, K. W., Tachikawa, Y., Ohno, O., Kitamura, M., Suganuma, M., & Uemura, D. (2009) · Journal of Natural Products · doi:10.1021/np900694j · Cited by 15
Suppressive Effect of Maslinic Acid on PMA-induced Protein Kinase C in Human B-Lymphoblastoid Cells
Mooi, L. Y., Yew, W. T., Yap, W. H., Soo, K. K., Hoon, L. S., & Chieng, Y. C. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.4.1177 · Cited by 15
“Hence, Protein Kinase C (PKC) is regarded as the prime target for cancer chemoprevention (Kanashiro & Khalil, 1998; Dempsey et al., 2000; Barry & Kazanietz, 2001; Ventura & Maioli, 2001; Griner & Kazanietz, 2007).”
BackgroundProtein Kinase C-β Gene Variants, Pathway Activation, and Enzastaurin Activity in Lung Cancer
Lee, S. H., Chen, T., Zhou, J. M., Hofmann, J., & Bepler, G. (2010) · Clinical Lung Cancer · doi:10.3816/clc.2010.n.021 · Cited by 15
Ritu, R., Goyal, R. K., Narwal, S., Bhatt, A., Sehrawat, R., Devi, P., Gulati, M., & Singla, R. K. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673316493240527113707 · Cited by 21
Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers
Gray, J. E., Altiok, S., Alexandrow, M. G., Walsh, F. W., Chen, J., Schell, M. J., Tai, D. F., & Bepler, G. (2012) · Cancer · doi:10.1002/cncr.27836 · Cited by 14
“In lung cancer cells, enzastaurin demonstrated inhibitory activity and modulation of intracellular signaling proteins.(13,21,22)”
BackgroundPotentials of PKC in Cancer Progression and Anticancer Drug Development
Deka, S. J., & Trivedi, V. (2018) · Current Drug Discovery Technologies · doi:10.2174/1570163815666180219113614 · Cited by 15
Caprioglio, D., Minassi, A., Avonto, C., Taglialatela‐Scafati, O., & Appendino, G. (2020) · Phytochemistry Reviews · doi:10.1007/s11101-020-09700-w · Cited by 14
“Compounds like phorbol miristate acetate (PMA) activate the enzymatic activity of canonical and novel protein kinase C isoforms by non-covalently shifting the conformational equilibrium of their target from a close, enzymatically inactive conformation, to an open and enzymatically active, but proteolytically labile, c…”
BackgroundMatsuda, K., Kobayakawa, T., Kariya, R., Tsuchiya, K., Ryu, S., Tsuji, K., Ishii, T. M., Gatanaga, H., Yoshimura, K., Okada, S., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.636276 · Cited by 15
Benefits and Challenges of Jatropha Meal as Novel Biofeed for Animal Production
Oskoueian, E., Oskoueian, A., Shakeri, M., & Jahromi, M. F. (2021) · Veterinary Sciences · doi:10.3390/vetsci8090179 · Cited by 14
“The activated PKC-β I induces the translocation of CD11b to the cell surface and affects cell differentiation.”
BackgroundInfluentialNovel regulation of protein kinase C-η
Pal, D., Outram, S. P., & Basu, A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.163 · Cited by 14
Garczarczyk, D., Szekér, K., Gálfi, P., Csordás, A., & Hofmann, J. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.02.035 · Cited by 14
Lee, H. J., Ji, Y., Paul, S., Maehr, H., Uskoković, M. R., & Suh, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1549 · Cited by 14
Protein kinase Cδ regulates vaccinia-related kinase 1 in DNA damage–induced apoptosis
Park, C.-H., Choi, B., Jeong, M.-W., Kim, S., Kim, W., Song, Y. S., & Kim, K. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0717 · Cited by 14
“Protein kinase C (PKC), a family of serine/threonine protein kinases , is activated by diverse stimuli and participates in cellular processes such as growth, differentiation, and apoptosis (Hug and Sarre, 1993; Griner and Kazanietz, 2007).”
BackgroundChen, J., Tsai, C., Lin, H., Huang, C., Leung, Y., Lai, S., Tsai, C., Chang, P.-C., Lu, D., & Lin, C. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9529-z · Cited by 14
Hayashi, Y., Nemoto‐Sasaki, Y., Matsumoto, N., Tanikawa, T., Oka, S., Tanaka, Y., Arai, S., Wada, I., Sugiura, T., & Yamashita, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.746602 · Cited by 14
“Cer is involved in regulating proapoptotic cell responses that include growth arrest and apoptosis (3), whereas DAG is involved in regulating prosurvival cell responses that include cell survival and proliferation (4).”
BackgroundTakahashi, D., & Sakane, F. (2018) · PeerJ · doi:10.7717/peerj.5449 · Cited by 14
Campbell, S., Franks, C. E., Borne, A. L., Shin, M., Zhang, L., & Hsu, K. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113001 · Cited by 14
“ABBREVIATIONS: 5-HTR, 5-hydroxytryptamine receptor; 5-HT2, serotonin receptor type 2; ANOVA, analysis of variance; DGKa, diacylglycerol kinase a; DMSO, dimethylsulfoxide; EGFR, epidermal growth factor receptor; ERK, extracellular signal-regulated kinase; FER, feline encephalitis virus-related kinase; HEK293T, human em…”
MethodInfluentialRobison, H. M., Chini, C. E., Comi, T. J., Ryu, S. W., Ognjanovski, E., & Perry, R. H. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02537-4 · Cited by 15
“4b, ESM Table S13), which is consistent with previous observations that DG serve as secondary messengers that promote cancer cell survival and metastasis via activation of protein kinase C [48].”
ResultGehring, M. P., & Pasquale, E. B. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109668 · Cited by 15
“We also examined the 3 members of the PRKD family because like conventional and novel PKCs they are also regulated by diacylglycerol (Table S1), and have thus been considered similar to PKCs (with PRDK1 also known as PKCμ and PRDK3 also known as PKCν) [18, 19].”
BackgroundTLR2 dimer‐specific ligands selectively activate protein kinase C isoforms in Leishmania infection
Mukherjee, A., Roy, S., Patidar, A., Bodhale, N. P., Dandapat, J., Saha, B., & Sarkar, A. (2021) · Immunology · doi:10.1111/imm.13373 · Cited by 14
Molecular Modeling, Total Synthesis, and Biological Evaluations of C9‐Deoxy Bryostatin 1
Keck, G. E., Poudel, Y. B., Rudra, A., Stephens, J. C., Kedei, N., Lewin, N. E., Peach, M. L., & Blumberg, P. M. (2010) · Angewandte Chemie · doi:10.1002/ange.201001200 · Cited by 14
Li, S., Zhang, D., Yang, L., Burnier, J. V., Wang, N., Lin, R., Lee, E. R., Glazer, R. I., & Brodt, P. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0197 · Cited by 15
Wang, J., Wang, H., Zhou, W., Luo, X., Wang, H., Meng, Q., Chen, J., Chen, X., Liu, Y., Chan, D. W., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci182217 · Cited by 16
“A critical role of DAG in signal transduction is its regulation of various cellular processes via the activation of PKC, which occurs when DAG binds to the C1 domains of PKC, prompting its phosphorylation (24).”
Colombo, D., Tringali, C., Franchini, L., Cirillo, F., & Venerando, B. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.043 · Cited by 13
Design, Synthesis, and Characterization of Novel sn -1 Heterocyclic DAG-Lactones as PKC Activators
Elhalem, E., Bellomo, A., Cooke, M., Scravaglieri, A., Pearce, L. V., Peach, M. L., Donadio, L. G., Kazanietz, M. G., & Comin, M. J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00739 · Cited by 13
Self-citationCooke, M., Zhang, X., Zhang, S., Eruslanov, E. B., Lal, P., Daniel, R. E., Feldman, M. D., Abba, M. C., & Kazanietz, M. G. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0170 · Cited by 14
Self-citationThe Role of PKC-θ in CD4+ T Cells and HIV Infection: To the Nucleus and Back Again
Phetsouphanh, C., & Kelleher, A. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00391 · Cited by 13
“PKC-θ can also be activated as a result of G-protein-coupled receptor and hormone receptor signaling (36).”
BackgroundBioinformatics approaches for identifying new therapeutic bioactive peptides in food
Khaldi, N. (2012) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v2i10.80 · Cited by 13
“J Agric Food Chem 2005, 53(21):8106-8115.”
Sand, J. M., Aziz, M. H., Dreckschmidt, N. E., Havighurst, T. C., Kim, K., Oberley, T. D., & Verma, A. K. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.212 · Cited by 13
“PKCe is among the major intracellular receptor for the mouse skin tumor promoter TPA (Mellor and Parker, 1998; Griner and Kazanietz, 2007) and is activated by a variety of stress factors including UVR (Wheeler et al.”
BackgroundPark, E., Min, H., Park, H. J., Chung, H., Ahn, Y., Pyee, J., & Lee, S. K. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11024fp · Cited by 15
Mackenzie, E. L., & Tsuji, Y. (2008) · Biochemical Journal · doi:10.1042/bj20071544 · Cited by 15
Bag, S., Dutta, D., Chaudhary, A., Sing, B. C., Banerjee, R., Pal, M., Paul, R. R., Basak, A., Das, A. K., Ray, A. K., et al. (2016) · RSC Advances · doi:10.1039/c6ra07001a · Cited by 13
Cha, H.-Y., Ahn, S. H., Cheon, J.-H., Park, S., & Kim, K. B. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.06.001 · Cited by 15
“Protein kinase C (PKC) is a well-known family of homologous serine/threonine kinases that play central roles in the regulation of various cellular functions in numerous cell types (Griner and Kazanietz, 2007).”
BackgroundProtein kinase C-eta regulates Mcl-1 level via ERK1
Pal, D., & Basu, A. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.012 · Cited by 13
Cell mimetic liposomal nanocarriers for tailored delivery of vascular therapeutics
Mattern‐Schain, S. I., Fisher, R. K., West, P., Grimsley, L. B., Harris, T. M., Grandas, O. H., Best, M. D., & Mountain, D. J. H. (2018) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2018.12.009 · Cited by 13
Isca, V. M. S., Senćanski, M., Filipović, N. R., dos Santos, D. J. V. A., Gašparović, A. Č., Saraiva, L., Afonso, C. A. M., Rijo, P. M., & García‐Sosa, A. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103671 · Cited by 14
“To date, 10 isozymes of PKC have been identified and can be grouped into three subfamilies: Classical (α, βI, βII, and γ), novel (δ, ε, η, and θ), and atypical PKCs (ζ and λ\ι) [17,19].”
Total Synthesis of Bryostatin 8 Using an Organosilane‐Based Strategy
Zhang, Y., Guo, Q., Sun, X., Lu, J., Cao, Y., Pu, Q., Chu, Z., Gao, L., & Song, Z. (2017) · Angewandte Chemie · doi:10.1002/ange.201711452 · Cited by 13
Rumsby, M. G., Schmitt, J., Sharrard, M., Rodrigues, G., Stower, M. J., & Maitland, N. J. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606077 · Cited by 14
“Protein kinase C alpha expression is reduced in many cancers (Koivunen et al, 2006; Griner and Kazanietz, 2007; Mackay and Twelves, 2007; Ali et al, 2009).”
BackgroundDesign and synthesis of protein kinase C epsilon selective diacylglycerol lactones (DAG-lactones)
Ann, J., Yoon, S., Baek, J., Kim, D. H., Lewin, N. E., Hill, C., Blumberg, P. M., & Lee, J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.025 · Cited by 13
Expression of Protein Kinase C Family in Human Hepatocellular Carcinoma
Lu, H., Chou, F., Yeh, K., Chang, Y., Hsu, N. C.-H., & Chang, J. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-009-9228-z · Cited by 13
“Within the cell, each PKC isoform mediates distinct functions including regulation of mitogenesis cell cycle, apoptosis and gene expression [13–21].”
BackgroundThe Pros and Cons of Targeting Protein Kinase c (PKC) in the Management of Cancer Patients
Leskow, F. C., Krasnapolski, M. A., & Urtreger, A. J. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798376950 · Cited by 13
Metadata
- Authors
- Griner, E. M., & Kazanietz, M. G.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kazanietz, Marcelo G.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04
- Volume
- 7
- Issue
- 4
- Pages
- 281-294
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1987496015
- Cited by
- 978
- References
- 190
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 16 · 2023: 28 · 2022: 32 · 2021: 35 · 2020: 47 · 2019: 35 · 2018: 46 · 2017: 56 · 2016: 55 · 2015: 44 · 2014: 80 · 2013: 66 · 2012: 71
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- protein kinase C, diacylglycerol, phorbol ester, tumor promotion, carcinogenesis, tumor progression, cell cycle regulation, apoptosis, malignant transformation, cell survival, small GTPases, signal transduction
- MeSH terms
- Cell Cycle, Diglycerides, Enzyme Activation, Humans, Isoenzymes, Neoplasms, Neovascularization, Pathologic, Peptide Hydrolases, Phorbol Esters, Protein Kinase C, Apoptosis, GTP Phosphohydrolases, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.